The Hematology & Blood Cancer Program at Cleveland Clinic Abu Dhabi provides specialized care and support for people diagnosed with malignant and non-malignant blood disorders. Our teams are experienced in diagnosing and treating a range of malignant and non-malignant blood disorders, including leukemia, lymphoma and multiple myeloma, as well as hereditary blood disorders, anemias, bleeding and clotting disorders and bone marrow disorders.
Program physicians also provide second opinion consultations for hematological malignancies and other non-malignant disorders. The skilled, multidisciplinary Hematology & Blood Cancer Program team supports the care of both outpatients and inpatients at Cleveland Clinic Abu Dhabi.
Every patient who visits the Hematology & Blood Cancer Program has a dedicated team of medical experts to support them, and their family, throughout their treatment journey. The multidisciplinary team round daily to discuss each patient’s needs, their progress and to decide the best treatment plan. We work closely with our team of experts at Cleveland Clinic in the US when needed, one of the largest and most respected hematology and blood cancer programs in the world, and home to one of the country’s only rare blood cancer clinics.
New research and developments in blood cancers have broadened the range of treatment options within this field. At Cleveland Clinic Abu Dhabi’s Hematology & Blood Cancer Program, we have access to the latest treatment options for patients with blood cancer, which can improve quality of life and survival rates.